Exenatide U.S. label context · version 1
This page preserves this version's wording and source pins. Open the current profile →
What does the U.S. product label say?
Exenatide injection · Read September 15, 2026 · Preserved label summary 1
Which population and use does the label cover?
This injection label covers glycemic control alongside diet and exercise in adults with type 2 diabetes. Its formulation-specific account does not substitute for extended-release exenatide labeling. Label: 1 ↗
Which safety limits matter?
Contraindications include severe hypersensitivity and prior exenatide-induced immune-mediated thrombocytopenia. Warnings address pancreatitis, hypoglycemia with insulin or insulin secretagogues, kidney injury from volume depletion, severe gastrointestinal reactions, antibodies, potentially fatal bleeding from immune-mediated thrombocytopenia, gallbladder disease and aspiration during anesthesia or deep sedation. Label: 4, 5 ↗
Label edition and source pins
U.S. product labeling hosted by the National Library of Medicine. This account concerns this product and label edition; other formulations and jurisdictions require their own records.
Exenatide injection · SPL version 17 · published 2026-06-30
Label ZIP SHA-256: 3a938f95f72fa59782922c490dc415fef7aa62df9872a1da096e4bff95b65abb. Extracted XML SHA-256: 18efb84e3d03a7719a6efd35e086f73cfc27232395a36db93da5fe7334894977.